Evidence map›Paper›PMID 34519783›Full record

ArticleNeuro-oncology2021

Corrigendum to: Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancer.

Weijun Wang, Haiping He, Nagore I Marín-Ramos, Shan Zeng, Steven D Swenson, Hee-Yeon Cho, Jie Fu, Paul M Beringer, Josh Neman, Ligang Chen and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuro-oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Weijun WangDepartment of Neurological Surgery, University of Southern California, Los Angeles, California, USA.ORCID 0000-0002-7430-5937
Haiping HeDepartment of Neurosurgery, Luzhou, China.
Nagore I Marín-RamosDepartment of Neurological Surgery, University of Southern California, Los Angeles, California, USA.
Shan ZengDepartment of Neurosurgery, Luzhou, China.
Steven D SwensonDepartment of Neurological Surgery, University of Southern California, Los Angeles, California, USA.
Hee-Yeon ChoDepartment of Neurological Surgery, University of Southern California, Los Angeles, California, USA.
Jie FuDepartment of Neurology Affiliated Hospital of Southwest Medical University, Luzhou, China.
Paul M BeringerDepartment of Clinical Pharmacy, Los Angeles, California, USA.
Josh NemanDepartment of Neurological Surgery, University of Southern California, Los Angeles, California, USA.
Ligang ChenDepartment of Neurosurgery, Luzhou, China.
Axel H SchönthalDepartment of Microbiology and Immunology, University of Southern California, Los Angeles, California, USA.
Thomas C ChenDepartment of Neurological Surgery, University of Southern California, Los Angeles, California, USA.

Funding

Innovative Nose-to-Brain Anticancer Drug Transport Facilitated by NEO100R41CA217551 · NCI · NEONC TECHNOLOGIES, INC. · PI CHEN, THOMAS C., WANG , WEIJUN · 2018 to 2019
$301k
NCI NIH HHS 1R41CA217551NCI NIH HHS R41 CA217551
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34519783
PMCPMC8643429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.